VITROS Immunodiagnostic Products hs Troponin I

Status unconfirmed

Conditions studied: Acute Coronary Syndrome (ACS), Myocardial Infarction

In brief

The purpose of this clinical study is to collect data to substantiate the use of the VITROS hs Troponin I test as an aid in the diagnosis of myocardial infarction (MI). The test is further indicated for risk stratification of mortality, myocardial infarction or coronary revascularization in patients with acute coronary syndrome.

Key facts

Study ID
NCT03581578
Run by
Ortho-Clinical Diagnostics, Inc.
People needed
1630
Starts
2018-06-07
Expected to finish
2021-06-01
Last updated by the study team
2020-09-16

Who can join

Age: 22 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.